BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12458555)

  • 1. All that glitters: the ups and downs of methamphetamine.
    Halkitis PN; Galatowitsch P
    Body Posit; 2002; 15(5):36-7. PubMed ID: 12458555
    [No Abstract]   [Full Text] [Related]  

  • 2. Methamphetamine and HIV.
    HRSA Careaction; 2009 Jun; ():1-8. PubMed ID: 19731419
    [No Abstract]   [Full Text] [Related]  

  • 3. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic.
    Urbina A; Jones K
    Clin Infect Dis; 2004 Mar; 38(6):890-4. PubMed ID: 14999636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse interactions with antiretroviral agents: focus on recreational and addiction drugs.
    Vassilev ZP; Marcus SM
    AIDS Read; 2004 Feb; 14(2):96. PubMed ID: 15083804
    [No Abstract]   [Full Text] [Related]  

  • 5. The challenging interactions between antiretroviral agents and addiction drugs.
    Khalsa J; Genser S; Vocci F; Francis H; Bean P
    Am Clin Lab; 2002 Apr; 21(3):10-3. PubMed ID: 12038078
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased HIV loads in active methamphetamine users explained by reduced effectiveness of antiretroviral therapy.
    AIDS Read; 2004 Feb; 14(2):70. PubMed ID: 14997860
    [No Abstract]   [Full Text] [Related]  

  • 7. Dangerous liaison: club drugs and HIV.
    Swanson J; Cooper A
    Posit Aware; 2003; 14(4):32-6. PubMed ID: 12951949
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs, drink'n and smok'n. Part I.
    Moreno M
    Surviv News (Atlanta Ga); 2001 Aug; ():11, 14. PubMed ID: 11682742
    [No Abstract]   [Full Text] [Related]  

  • 9. How some HIV clinics handle substance abuse.
    Clements A; Gerse M; Mabry SH
    AIDS Alert; 2001 Aug; 16(8):95-7. PubMed ID: 11547704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance.
    Colfax GN; Vittinghoff E; Grant R; Lum P; Spotts G; Hecht FM
    AIDS; 2007 Jan; 21(2):239-41. PubMed ID: 17197817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal methamphetamine use and antiretroviral drug resistance: a pilot study of behavioral and clinical correlates.
    Ghaziani A
    IAPAC Mon; 2005 Oct; 11(10):297-9. PubMed ID: 16673497
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV medications + street drugs: some cocktails don't mix.
    Notes Undergr; 1998-1999 Winter; (No 38):1, 4-5. PubMed ID: 11366194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse and HIV infection.
    Francis H
    Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIDA seeking data on effect of fetal exposure to methamphetamine.
    Marwick C
    JAMA; 2000 May; 283(17):2225-6. PubMed ID: 10807367
    [No Abstract]   [Full Text] [Related]  

  • 16. Club drugs and HIV infection: a review.
    Colfax G; Guzman R
    Clin Infect Dis; 2006 May; 42(10):1463-9. PubMed ID: 16619161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed ischemic stroke associated with methamphetamine use.
    Ohta K; Mori M; Yoritaka A; Okamoto K; Kishida S
    J Emerg Med; 2005 Feb; 28(2):165-7. PubMed ID: 15707812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk and protective factors for methamphetamine use and nonmedical use of prescription stimulants among young adults aged 18 to 25.
    Herman-Stahl MA; Krebs CP; Kroutil LA; Heller DC
    Addict Behav; 2007 May; 32(5):1003-15. PubMed ID: 16920275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems.
    Kumar S; Rao PS; Earla R; Kumar A
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):343-55. PubMed ID: 25539046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.